IL6 and amyotrophic lateral sclerosis: Regarding the potential role of interleukins as prognostic biomarkers, rising levels of IL-4, IL-6 and IL-13 in CSF or blood from ALS patients were associated with disease progression and ALSFRS-R score [26,56,64] (Table 1).